XNASSOPH
Market cap216mUSD
Dec 23, Last price
3.31USD
1D
1.53%
1Q
-11.73%
IPO
-80.53%
Name
Sophia Genetics SA
Chart & Performance
P/E
—
P/S
3.47
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
62m
+31.14%
Net income
-79m
L-9.68%
CFO
-49m
L-30.70%
Earnings
Mar 03, 2025
Profile
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 62,371 31.14% | 47,560 17.58% | 40,450 42.43% | |||
Cost of revenue | 138,151 | 135,760 | 112,047 | |||
Unusual Expense (Income) | ||||||
NOPBT | (75,780) | (88,200) | (71,597) | |||
NOPBT Margin | ||||||
Operating Taxes | 486 | (136) | 168 | |||
Tax Rate | ||||||
NOPAT | (76,266) | (88,064) | (71,765) | |||
Net income | (78,981) -9.68% | (87,449) 18.70% | (73,675) 87.28% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 226 | 748 | 231,311 | |||
BB yield | -0.07% | -0.57% | -25.69% | |||
| Debt | ||||||
Debt current | 2,928 | 2,690 | 1,813 | |||
Long-term debt | 34,274 | 30,796 | 24,305 | |||
Deferred revenue | ||||||
Other long-term liabilities | 3,420 | 2,845 | 4,924 | |||
Net debt | (86,049) | (145,126) | (239,201) | |||
| Cash flow | ||||||
Cash from operating activities | (48,575) | (70,093) | (57,939) | |||
CAPEX | (1,494) | (10,381) | (6,671) | |||
Cash from investing activities | 8,320 | 41,973 | (56,934) | |||
Cash from financing activities | (2,817) | (1,568) | 237,773 | |||
FCF | (77,973) | (93,506) | (82,181) | |||
| Balance | ||||||
Cash | 123,251 | 178,612 | 265,319 | |||
Long term investments | ||||||
Excess cash | 120,132 | 176,234 | 263,296 | |||
Stockholders' equity | (319,758) | (271,376) | (195,487) | |||
Invested Capital | 493,221 | 490,738 | 487,979 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 64,751 | 64,099 | 63,858 | |||
Price | 4.71 128.64% | 2.06 -85.39% | 14.10 | |||
Market cap | 304,977 130.97% | 132,044 -85.33% | 900,392 | |||
EV | 218,928 | (13,082) | 661,191 | |||
EBITDA | (67,444) | (82,629) | (67,988) | |||
EV/EBITDA | 0.16 | |||||
Interest | 588 | 639 | 658 | |||
Interest/NOPBT | ||||||